Don't let Ab­b­Vie fool FTC with an easy di­vesti­ture, plead crit­ics in lat­est at­tack on $63B Al­ler­gan buy­out

If the FTC must let Ab­b­Vie and Al­ler­gan go ahead with their merg­er, at least make them di­vest their lat­est block­buster on the mar­ket, a cho­rus of unions, con­sumer groups and pub­lic in­ter­est or­ga­ni­za­tions plead in a new at­tempt to rein in the megamerg­er.

There’s a sec­ond part to their ar­gu­ment: If the an­titrust watch­dog does green­light the di­vesti­ture Ab­b­Vie wants, then at least en­sure the phar­ma gi­ant can­not cor­ner its fu­ture ri­vals with its ex­clu­sion­ary tac­tics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.